Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 3.060
-0.020 (-0.65%)
At close: Mar 18, 2026
Artrya Revenue
Artrya had revenue of 14.00K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 29.00K, up 123.08% year-over-year. In the fiscal year ending June 30, 2025, Artrya had annual revenue of 28.00K.
Revenue (ttm)
29.00K
Revenue Growth
+123.08%
P/S Ratio
16,680.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
483.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 28.00K | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cogstate | 84.06M |
| Alcidion Group | 48.62M |
| Mach7 Technologies | 29.70M |
| Beamtree Holdings | 28.90M |
| PharmX Technologies | 7.65M |
| Vitasora Health | 5.01M |
| PainChek | 3.44M |
| Emyria | 2.29M |